Results 321 to 330 of about 3,326,153 (390)
Some of the next articles are maybe not open access.
Activation of Bovine Plasminogen by the Plasminogen Activator in Animal Tissue
Thrombosis and Haemostasis, 1960Summary1. The activation of bovine plasminogen by means of the plasminogen activator from pig heart tissue has been studied on heated fibrin and on casein.2. Small, but varying, amounts of activator can be extracted from crude activator powder during the experiment and interfere therefore with estimations on normal, plasminogen containing fibrin.3. The
Takeshi Abe, Tage Astrup
openaire +3 more sources
Bacterial plasminogen activators and receptors.
FEMS Microbiology Reviews, 2001Invasive bacterial pathogens intervene at various stages and by various mechanisms with the mammalian plasminogen/plasmin system. A vast number of pathogens express plasmin(ogen) receptors that immobilize plasmin(ogen) on the bacterial surface, an event ...
K. Lähteenmäki +2 more
semanticscholar +1 more source
Urokinase-type and tissue-type plasminogen activators as growth factors of human fibroblasts.
Experimental Cell Research, 1994In this study we have verified the mitogenic effect of urokinase-type (u-PA) and tissue-type plasminogen activators (t-PA) on human normal fibroblasts. We report that both PAs can induce DNA replication and cell division in serum-deprived cultured human ...
G. D. Petro, A. Copeta, S. Barlati
semanticscholar +1 more source
Circulation Research, 1996
The expression of plasminogen activators and inhibitors was examined in denuded arteries. Within 5 days, smooth muscle cells (SMCs) on the luminal surface expressed the mRNA for tissue-type plasminogen activator (TPA), urokinase type plasminogen (UPA ...
M. Reidy, C. Irvin, V. Lindner
semanticscholar +1 more source
The expression of plasminogen activators and inhibitors was examined in denuded arteries. Within 5 days, smooth muscle cells (SMCs) on the luminal surface expressed the mRNA for tissue-type plasminogen activator (TPA), urokinase type plasminogen (UPA ...
M. Reidy, C. Irvin, V. Lindner
semanticscholar +1 more source
Tissue Activator of Plasminogen
Nature, 1964SINCE Astrup and Permin1 reported that animal tissue cells contain an activator of plasminogen, various authors have confirmed their results, and comparisons of the activator content of different human2 and animal tissues3,4 have been published. Most authors have used whole tissue or aqueous tissue extracts and have estimated activity by the fibrin ...
Charles H. Lack, S. Yousuf Ali
openaire +3 more sources
Platelets and Plasminogen Activation
Thrombosis and Haemostasis, 1995Platelets serve as a site for assembly of the proteins of the plasminogen activator system. Once bound to the platelet surface, tissue-type plasminogen activator manifests enhanced catalytic activity. Plasmin, once formed, also binds to the platelets surface and, at low concentrations, renders the platelet dysfunctional by cleaving glycoprotein IIIa ...
Joseph Loscalzo +3 more
openaire +3 more sources
Circulation, 1997
BACKGROUND Coronary thrombus is composed of platelets and fibrin, and during thrombolytic treatment, reflow may be slowed by platelet deposition. It may be possible to initiate coronary reflow without exogenous plasminogen activators by blocking platelet
H. Gold +6 more
semanticscholar +1 more source
BACKGROUND Coronary thrombus is composed of platelets and fibrin, and during thrombolytic treatment, reflow may be slowed by platelet deposition. It may be possible to initiate coronary reflow without exogenous plasminogen activators by blocking platelet
H. Gold +6 more
semanticscholar +1 more source
Regulation of the synthesis and secretion of plasminogen activators by endothelial cells.
Haemostasis, 1988Plasminogen activators (PAs) play a role in fibrinolysis, tissue remodelling, tumor invasion, and reparative processes. Vascular endothelial cells produce tissue-type PA (t-PA), an important regulator of fibrinolysis, and PA inhibitor 1.
V. Hinsbergh
semanticscholar +1 more source
Plasminogen activator / plasminogen activator inhibitors in ovarian physiology
Frontiers in Bioscience, 2004The target extracellular matrix (ECM) degradation generated by plasminogen activator (PA) and regulated by plasminogen activator inhibitor (PAI) is an event that affects a wide variety of physiological and pathological processes in the ovary. Studies carried out over the past 25 years in a number of laboratories have elucidated some of the biochemical ...
openaire +3 more sources
Plasminogen activators: A comparison
Vascular Pharmacology, 2006Thrombolytic drugs play a crucial role in the management of patients with acute myocardial infarction, pulmonary embolism, deep vein thrombosis, arterial thrombosis, acute thrombosis of retinal vessel, extensive coronary emboli, and peripheral vascular thromboembolism.
M.R. Chaudhari +3 more
openaire +3 more sources